RBF Capital’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98K | Hold |
163,261
| – | – | ﹤0.01% | 563 |
|
|
2025
Q1 | $44.1K | Hold |
163,261
| – | – | ﹤0.01% | 551 |
|
|
2024
Q4 | $84.9K | Sell |
163,261
-2,213
| -1% | -$1.15K | ﹤0.01% | 525 |
|
|
2024
Q3 | $536K | Hold |
165,474
| – | – | 0.03% | 397 |
|
|
2024
Q2 | $496K | Hold |
165,474
| – | – | 0.03% | 375 |
|
|
2024
Q1 | $769K | Hold |
165,474
| – | – | 0.04% | 324 |
|
|
2023
Q4 | $685K | Sell |
165,474
-28,600
| -15% | -$118K | 0.04% | 320 |
|
|
2023
Q3 | $582K | Hold |
194,074
| – | – | 0.04% | 330 |
|
|
2023
Q2 | $477K | Buy |
+194,074
| New | +$477K | 0.03% | 369 |
|